We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Mirum Pharmaceuticals
MIRM
$7.24B
| $8.11M | 0.01% |
102,703
+62,871
| +158% | +$4.51M |
|
|
ABVX
927
Abivax
ABVX
$11.9B
| $8.06M | 0.01% |
59,758
-129,946
| -68% | -$14.2M |
|
|
DCH
928
Dauch Corp
DCH
$1.29B
| $8.05M | 0.01% |
1,256,037
+775,502
| +161% | +$4.82M |
|
929
SmartRent
SMRT
$187M
| $8.01M | 0.01% |
3,964,108
+1,006,267
| +34% | +$1.65M |
|
930
Las Vegas Sands
LVS
$30B
| $7.99M | 0.01% |
122,814
-715,689
| -85% | -$43.9M |
|
931
Federal Agricultural Mortgage
AGM
$2.22B
| $7.99M | 0.01% |
45,525
+7,924
| +21% | +$1.33M |
|
932
First Watch Restaurant Group
FWRG
$767M
| $7.96M | 0.01% |
527,692
-1,113,513
| -68% | -$18.8M |
|
933
Dave Inc
DAVE
$5.6B
| $7.93M | 0.01% |
35,803
+31,488
| +730% | +$6.77M |
|
934
BCE
BCE
$20.4B
| $7.91M | 0.01% |
332,278
+285,835
| +615% | +$6.66M |
|
935
CleanSpark
CLSK
$3.34B
| $7.91M | 0.01% |
+781,147
| New | +$11.7M |
|
936
Cincinnati Financial
CINF
$28B
| $7.87M | 0.01% |
+48,191
| New | +$7.81M |
|
937
Assurant
AIZ
$13.7B
| $7.86M | 0.01% |
+32,614
| New | +$7.28M |
|
938
Snowflake
SNOW
$93.2B
| $7.84M | 0.01% |
35,762
+19,489
| +120% | +$4.76M |
|
939
iShares US Healthcare ETF
IYH
$3.2B
| $7.84M | 0.01% |
+120,459
| New | +$7.6M |
|
940
IHS Holding
IHS
$2.74B
| $7.84M | 0.01% |
1,050,722
-440,312
| -30% | -$3.03M |
|
941
Theravance Biopharma
TBPH
$877M
| $7.83M | 0.01% |
418,629
+60,978
| +17% | +$1.01M |
|
942
MP Materials
MP
$8.06B
| $7.83M | 0.01% |
154,891
-516,281
| -77% | -$32.7M |
|
|
B
943
Barrick Mining
B
$58.5B
| $7.81M | 0.01% |
179,259
-710,400
| -80% | -$26.7M |
|
944
Root
ROOT
$944M
| $7.77M | 0.01% |
107,612
+57,870
| +116% | +$4.61M |
|
|
PCH
945
DELISTED
PotlatchDeltic
PCH
| $7.76M | 0.01% |
195,128
+23,621
| +14% | +$956K |
|
946
Tactile Systems Technology
TCMD
$648M
| $7.7M | 0.01% |
+265,517
| New | +$5.89M |
|
947
Leidos
LDOS
$13.4B
| $7.7M | 0.01% |
42,660
+36,626
| +607% | +$6.94M |
|
948
GrafTech
EAF
$181M
| $7.68M | 0.01% |
494,865
+99,411
| +25% | +$1.51M |
|
949
Payoneer
PAYO
$2.41B
| $7.66M | 0.01% |
1,362,962
+960,371
| +239% | +$5.55M |
|
950
Nice
NICE
$5.87B
| $7.61M | 0.01% |
67,284
+14,360
| +27% | +$1.73M |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.